Allergan expected to post EPS of $4.73 for 2017 — 3 insights

Stock market analysts anticipate Allergan will report full-year earnings of $4.73 per share Feb. 14, according to the Frisco Fastball.


Here's what you should know:

1. Analysts believe Allergan will announce fourth quarter 2017 earnings of $0.83 per share Feb. 14, as well.

2. Analysts believe the company's full-year earnings will increase approximately 13.98 percent, year over year.

3. Based on the projected earnings, 18 analysts awarded Allergan a "buy" rating and eight have deemed it a "hold." No analysts issued a "sell" rating.

Copyright © 2023 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers

Featured Podcast